Back

Efficacy and safety of pharmacoinvasive strategy compared with primary PCI in patients with STEMI presenting to non-PCI hubs: A real world study

13 March 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Live Abstract session - Acute Coronary Syndromes 2 - Focus on systems of care Revascularisation ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Andrea Gallardo-Grajeda

ABC Medical Center, Mexico City (Mexico)

6 More presentations in this session

Presentation thumbnail
First medical contact place determines prognosis in a regional STEMI network. Is time the most important factor?
Doctor O. De Diego Soler (Barcelona, ES)
Abstract
Presentation thumbnail
Prevalence and main causes of myocardial infarction type 2 in the structure of in-hospital mortality
Associate Professor I. Leonova (Saint Petersburg, RU)
Abstract
Presentation thumbnail
Time to percutaneous coronary intervention in patients with ST-elevation myocardial infarction undergoing successful systemic fibrinolysis: does early or late make a difference?
Doctor C. Jackson-Pedroza (Mexico City, MX)
Abstract
Presentation thumbnail
An analysis based on sex&gender in the chest pain unit of an emergency department during the last 12 years.
Ms G. Martinez-Nadal (Barcelona, ES)
Abstract
Presentation thumbnail
Women and elderly: do we delay treatment even after identifying ST-segment elevation?
Doctor P. Araujo Leite Medeiros (Braga, PT)
Abstract

Access the full session

Session thumbnail
Live Abstract session - Acute Coronary Syndromes 2 - Focus on systems of care

The Event

Event poster

ACVC 2021

13 March - 14 March 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources